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Role of Virus-Encoded microRNAs 
in Avian Viral Diseases
Venugopal Nair and Yongxiu Yao
Abstract
To survive in the host cells, viruses have to adapt various strategies, which 
include the modulation of microRNA (miRNA) pathway through virus-encoded 
miRNAs to modulate the host cellular environment. It has been shown that several 
avian viruses, mostly herpesviruses, encode a number of miRNAs. These include 
26 miRNAs encoded by the highly oncogenic Marek’s disease virus-1, 36 miRNAs 
encoded by avirulent Marek’s disease virus-2, 28 miRNAs by herpesvirus of turkeys, 
10 miRNAs by infectious laryngotracheitis virus, 41 miRNAs by duck enteritis 
virus, and 2 miRNAs by avian leukosis virus subgroup J. Although locations of some 
of the miRNAs are conserved within the repeat regions of the genomes among 
some of the antigenic and phylogenetic closely related herpesviruses, there are 
no sequence conservation of miRNAs encoded by different avian herpesviruses. 
Moreover, some of the virus-encoded miRNAs have the same seed sequence as host 
miRNAs serve as functional orthologs. For example, mdv1-miR-M4-5p, a functional 
ortholog of gga-miR-155, is critical for the Marek’s disease virus in inducing tumors. 
In this review, we describe the advances in our understanding on the role of the 
herpesvirus-encoded miRNAs in avian diseases. Additionally, we also describe the 
potential association of avian leukosis virus subgroup J encoded E (XSR) miRNA in 
the induction of myeloid tumors in certain genetically distinct chicken lines.
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1. Introduction
MicroRNAs (miRNAs) are small RNA molecules of ~22-nucleotide that pro-
foundly affect gene expression by targeting the 3’UTR (untranslated region) of 
the targeted mRNA (messenger RNA). Ever since the first discovery of miRNA 
in Caenorhabditis elegans [1], the identification of miRNAs, of which some are 
evolutionarily conserved [2–4], has proceeded at a quick pace. It is well known 
now that miRNAs are key regulators of gene expression in many species including 
mammals, plants, flies, worms, as well as in a number of viruses. Out of 38,589 
miRNAs identified so far, 530 are encoded by viruses (www.miRbase.org). Most 
of the viral miRNAs are encoded by DNA viruses, with members of the family 
Herpesviridae encoding for the vast majority suggesting the importance of miRNA-
mediated gene regulation in the biology of herpesvirus infections. Long-term 
survival as latent infections in different cell types are characteristic feature of 
virus-host interactions in herpesviruses. This requires sophisticated survival strat-
egy to avoid detection by the innate and adaptive immune mechanisms of the host. 
Herpesviruses achieve this using a variety of mechanisms through translational 
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control, epigenetic control of viral/host gene expression, and restricted gene 
expression [5, 6]. The miRNAs, with the small size along with the ability for 
specific repression of multiple transcript targets, make them ideal tools for herpes-
viruses to reshape the gene expression to favor viral replication in an infected cell. 
Hence, it is of no surprise that herpesviruses encode 91% of virus-encoded miR-
NAs identified so far. The number of miRNAs encoded by different herpesviruses 
varies, i.e., 5 miRNAs in Bovine herpesvirus 5 and 70 in Rhesus lymphocryptovirus 
(miRBase V22.1). In addition to herpesviruses, some of other virus families also 
encode miRNAs [7, 8] including miRNAs encoded by the human Torque Teno Virus 
[9]. Although retroviruses have not been widely documented to exploit the miRNA 
pathway [10], demonstration of E (XSR) miRNA encoded by avian leukosis virus 
subgroup J (ALV-J) using the canonical miRNA biogenesis pathway [11], and a 
conserved cluster of RNA polymerase III (pol III)-transcribed miRNAs from the 
bovine leukemia virus (BLV) genome [12, 13] showed that retroviruses also exploit 
the miRNA pathway.
2. miRNA-encoding avian viruses and associated diseases
Avian herpesviruses are a major group of pathogens affecting different spe-
cies of poultry. All of the pathogenic avian herpesviruses belong to the subfamily 
Alphaherpesvirinae. These include infectious laryngotracheitis virus (ILTV, Gallid 
herpesvirus) in the Iltovirus genus, pathogenic Marek’s disease virus-1 (MDV-1, 
Gallid herpesvirus 2) in Mardivirus genus, and unassigned duck enteritis virus 
(DEV). ILTV induces laryngotracheitis, a contagious respiratory tract infection 
that results in severe losses in egg production and high mortality in infected poultry 
flocks. Although the safety of vaccine strains has been questionable, live attenuated 
vaccines are used to control this disease [14]. Mardivirus genus is classified into 
three closely related, but distinct groups including the pathogenic Marek’s disease 
virus-1 (MDV-1, Gallid herpesvirus 2), attenuated Marek’s disease virus-2 (MDV-2, 
Gallid herpesvirus 3), and the antigenically related herpesvirus of turkey (HVT, 
Meleagrid herpesvirus 1). Based on their pathogenicity, MDV-1 is further grouped 
into different pathotypes named as virulent (vMDV), very virulent (vvMDV), and 
very virulent plus (vv + MDV) [12]. Marek’s disease (MD) is an immunosuppres-
sive, neurological, and oncogenic disease caused by highly contagious MDV-1. MD 
that is widespread in the poultry population around the world causes estimated 
economic losses of US$ 2000 million annually [15]. Although, controlled by the 
use of vaccines such as nonpathogenic HVT and MDV-2 vaccines or live attenu-
ated MDV-1 strains [16], there is concern on the continued evolution of the virus 
toward greater virulence, challenging the sustainability of Marek’s disease vaccina-
tion strategy [17, 18]. DEV induces acute disease in waterfowl species with high 
 mortality [19, 20].
Avian leukosis viruses (ALVs) are members of Alpharetrovirus genus of the 
Retroviridae family. ALVs cause neoplastic diseases and other reproduction prob-
lems with enormous economic losses in the global poultry industry. According to 
their mode of transmission, the ALVs are classified as either endogenous (ALV-E) 
or exogenous viruses. Based on viral envelope interference, host range, and cross-
neutralization patterns, exogenous ALVs from chickens have been further divided 
into different subgroups (A, B, C, D, and J) [21]. ALV-J was first described in the 
UK in the late 1980s [22] and has been primarily associated with myeloid leukosis 
in meat-type chickens. ALV-J caused more serious damage than all other subgroups 
worldwide. ALV-induced disease particularly by ALV-J is still widespread in poultry 
population in China and causes huge economic losses [23].
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3. Identification of miRNAs encoded by avian viruses
The majority of viral miRNAs had initially been identified by a protocol involving 
size fractionation of small RNA, ligation of linkers, reverse transcription, concatamer-
ization, cloning followed by Sanger sequencing [7]. The bioinformatics approaches to 
identify miRNA-encoding loci in viral genome based on commonalities in the predi-
cated secondary structures of pre-miRNAs have also been developed. Exploring the 
small RNAs libraries with a higher degree of reliability and unprecedented depth has 
become possible with the advent of massively parallel sequencing technologies. We 
and others have reported the identification of miRNAs encoded by a number of avian 
herpesviruses. These include 14 miRNAs (26 mature sequences) encoded by MDV-1 
[24, 25], 18 miRNAs (36 mature sequences) encoded by MDV-2 [26, 27], 17 miRNAs 
(28 mature sequences) encoded by HVT [27, 28], 7 miRNAs (10 mature sequences) 
encoded by ILTV [27, 29], 24 miRNAs (33 mature sequences) encoded by DEV [30], 
and 1 miRNA (2 mature sequences) encoded by ALV-J [11] (Figure 1).
3.1 MDV-1 miRNAs
High throughput sequencing of small RNA libraries from highly virulent RB1B 
strain infected chicken embryo fibroblast (CEF) has led to the identification of the 
first MDV-1-encoded miRNAs in 2006 [24]. Subsequently, more MDV-1 miRNAs 
were discovered by analyzing small RNA library of MSB-1, a MDV-1 cell line 
established from an MDV-induced spleen lymphoma [25, 31]. A total of 14 precur-
sor sequences producing 26 mature miRNAs have been identified from the MDV-1 
genome (www.miRbase.org; Figure 1A). The MDV-1 miRNAs are clustered in three 
separate genomic loci: cluster 1 (Meq-cluster), cluster 2 (Mid-cluster) flank the Meq 
oncogene, and cluster 3 (LAT-cluster) lies in the region encoding the latency-asso-
ciated transcripts (LATs) [24, 25, 31] (Figure 1A). All three MDV-1 miRNA clusters 
are in the repeat regions of the viral genome. Although differing in virulence, the 
miRNA sequences are highly conserved among 23 different MDV-1 strains [31, 32]. 
Despite this, the expression level of Meq-cluster miRNAs is higher in vv+ MDV-
induced lymphomas than vvMDV strain-induced lymphomas. One polymorphism 
in the miRNA promoter region has been proposed to be responsible for this differ-
ential expression. On the other hand, there is no difference on the level of the LAT-
cluster miRNAs expression [31, 33], implying that miRNAs from Meq-cluster may 
play a more significant role in MD oncogenesis. Indeed, the significantly decreased 
oncogenicity of the virus with the deletion of the Meq-cluster miRNAs has proved 
this hypothesis [34, 35]. mdv1-miR-M4-5p, a functional ortholog of gga-miR-155 
and a member of Meq-cluster miRNA, is the most highly expressed viral miRNA in 
tumors, representing over 70% of MDV miRNA sequencing reads [31]. Similar to 
the role of gga-miR-155 in lymphoid malignancies, mdv1-miR-M4-5p was shown to 
play a key role in MDV-1-induced oncogenesis [34, 35]. The promoter prmiRM9M4, 
corresponding to the 1300-bp immediately upstream from the first Meq-cluster 
miRNA mdv1-miR-M9, has been shown to drive the transcription of both Meq-
cluster and Mid-cluster miRNAs with two distinct transcriptional models during 
different infection phases [33]. Indeed, this promoter has been shown to be active 
during MDV-1 latency by both DNA hypomethylation and active histone marks 
[36], confirming its transcriptional activity. In contrast, the transcription of LAT-
clustered miRNAs is driven by a p53-dependent promoter, which contains at least 
two 60-bp tandem repeats harboring a p53-response element but has no consensus 
core promoter element [37].
Studies on correlation of miRNA expression signature with MDV-
transformation have been undertaken. Microarray analysis has been carried 
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out to determine the global miRNA expression profiles in seven distinct MDV-
transformed cell lines [38]. Compared to uninfected splenocytes and CD4+ T-cells 
or non-MDV avian viral transformed cell lines, these profiles revealed that the 
expression of a set of host miRNAs is altered in the MDV-transformed cell lines. 
The downregulated host miRNAs in the MDV-transformed cell lines include 
miR-26a, miR-150, miR-223, miR-155, and miR-451. The differential expression of 
these host miRNAs may contribute to MDV pathogenesis, considering the link of 
several mammalian homologs of these miRNAs with cancer development [39]. For 
example, miR-26a with tumor suppressor function is downregulated in a number 
of avian lymphoma cells. miR-26a has been shown to regulate interleukin 2 (IL-2) 
expression [40]. It is well known that IL-2 regulates T-cell proliferation, suggesting 
that downregulation of miR-26a and the upregulation of IL-2 expression could be a 
conserved mechanism in avian viral transformation. Taken together, analysis of the 
functional targets of the differentially expressed miRNAs would contribute toward 
better understanding of the molecular pathways of MD oncogenicity.
3.2 MDV-2 miRNAs
MSB-1 is a MDV-transformed lymphoblastoid cell line, which is co-infected with 
both BC-1 strain of MDV-1 and HPRS24 strain of MDV-2 [41]. About 17 novel MDV-2 
miRNAs were identified by analyzing small RNA library from MSB-1 [26]. Of these, 
16 are expressed in the same direction and clustered in a 4.2-kb long repeat region 
that encodes R-LORF2 to R-LORF5, suggesting that they may be derived from a com-
mon primary transcript. The single miRNA outside the cluster was located within the 
C-terminal region of the ICP4 homolog in the short repeat region. Despite lacking 
sequence homology, the relative genomic positions of miRNA clusters in MDV-1 
and MDV-2 are conserved by locating within the repeat regions of the viral genome. 
Subsequently, an additional miRNA mdv2-miR-M32 has been reported by high 
throughput sequencing of small RNAs from MSB-1 cells [27]. Uniquely, all 18 MDV-2 
encoded miRNA precursors give rise to 2 mature forms resulting in 36 mature MDV-2 
miRNAs, representing both strands of the duplex (www.miRbase.org; Figure 1A). 
Two separate studies on sequencing of MSB-1 small RNA library showed that MDV-2 
miRNAs accounted for 10 and 13% of the sequencing reads, respectively [25, 27].
3.3 HVT miRNAs
HVT-encoded miRNAs were identified from HVT-infected CEF using both 
traditional cloning and sequencing of a small RNA library [28] and high throughput 
sequencing technology [27]. About 17 precursor miRNAs producing 28 mature 
miRNAs (www.miRbase.org; Figure 1A) have been identified in the HVT genome. 
Except for miR-H11, which is located within an intron of UL21 in the UL region, 
all other HVT miRNAs are located in the long-repeat regions, demonstrating 
some degree of positional conservation with MDV-1 and MDV-2. Interestingly, 
10 HVT miRNAs were located in a region containing two tandem repeats, and small 
sequence variations were observed following multiple sequence alignment of the 
miRNA precursors, suggesting evolution by duplication. This represents the first 
example of evolution of virus-encoded miRNAs by duplication.
3.4 ILTV-miRNAs
A total of seven ILTV precursor miRNAs producing 10 mature miRNAs from 
ILTV-infected chicken embryo kidney (CEK) cells and leghorn male hepatoma 
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(LMH) cell line have been identified by deep sequencing of small RNA populations 
[27, 29] (www.miRbase.org; Figure 1B). Four of the miRNAs (iltv-miR-I1-I4), 
which are not associated with any annotated ORFs were located at the extreme 
terminus of the ILTV genome. miR-I5 and miR-I6, the two most highly expressed 
miRNAs, are located in the repeat regions within ICP4. The iltv-miR-I7 was mapped 
in the replication origin (oriL) of the palindrome stem loop sequence. Out of seven 
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miRNAs, only three (iltv-miR-I3, -I5, -I6) have been confirmed by Northern hybrid-
izations although the expression was confirmed for all by the end point PCR using 
small RNA libraries generated from ILTV-infected CEK.
Figure 1. 
Diagrammatic representation of the viral genomes showing the positions of miRNAs of MDV1, MDV2, HVT 
(A) and ILTV, DEV and ALV-J (B). Position and orientation of selected transcripts are shown. The genome 
size (base pairs) of viruses is shown on the top-left corner. Adapted from Yao et al., [92].
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3.5 DEV miRNAs
About 33 mature miRNAs derived from 24 pre-miRNA sequences within 
the DEV genome have been identified by deep sequencing of small RNAs from 
DEV vaccine strain-infected CEF cultures [30] (www.miRbase.org; Figure 1B). 
Compared to the location of most Mardivirus-encoded miRNAs which are at the 
repeat regions, genomic positions of DEV-encoded miRNAs are unique. Five out of 
six miRNA clusters from both the coding and non-coding regions of the 158,091-bp 
viral genome were encoded within the unique long region. Similar to miRNA-offset 
RNAs, two miRNA precursors, DEV miR-D18 and miR-D19, overlapped with each 
other although only the dev-miR-D18-3p was functional in reporter assays. In addi-
tion, 12 putative DEV miRNAs have been reported by computational approach [42], 
none of these miRNAs overlapped with the 24 DEV miRNAs described above [30]. 
In a recent report, 39 mature viral miRNAs have been identified from a Chinese 
virulent strain of DEV infected duck embryo fibroblast cells [43]. Of those, only 13 
miRNA sequences and 22 “seed sequences” of miRNA were identical with the previ-
ously reported DEV-miRNAs encoded by vaccine strain [30]. About eight additional 
viral miRNAs were detected and confirmed by stem-loop RT-qPCR [43].
3.6 ALV-J miRNAs
One of the distinct features of HPRS-103 sequence, the ALV-J prototype 
virus, is the presence of E (also called XSR) element, a distinct hairpin stem-loop 
structure in the 3′ untranslated region. Indeed, the expression of miRNA from 
this hairpin-like structure of E element has been demonstrated in ALV-J-infected/
transformed cells [11]. E (XSR) miRNA, a small RNA population encoded from 
within the E (XSR) element, was identified using deep sequencing approach on 
ALV-J-transformed cell line IAH30 [11] (Figure 1B). E (XSR) miRNA is suggested 
to play a major role in ALV-J pathogenesis and neoplastic transformation as it 
accounted for a quarter of the sequences of the IAH30 “miRNAome.” Although the 
E element per se is not absolutely essential for ALV-J induced tumor, the E element 
does contribute to the oncogenicity in certain genetic lines of chicken when the 
oncogenicity of viruses derived from the parental and E element deleted HPRS-103 
viruses was compared [44]. The hypothesis of polymorphisms, particularly those in 
any potential E (XSR) miRNA target sites could account for differential susceptibil-
ity phenotypes among these lines can be investigated by comparison of the genomes 
of these lines.
4. Viral orthologs of host miRNAs
Two classes of virus-encoded miRNAs are grouped: viral specific miRNAs 
and orthologs of host miRNAs. Similar to some viral regulatory proteins, several 
viral miRNAs have evolved to mimic host effectors. The “seed” region of a miRNA 
(~nucleotides 2–8 at the 5′ end) plays a key role in directing RISC to its mRNA 
targets. Binding with perfect seed complementary to the target transcript takes 
~60% of regulation by a particular miRNA [45]. Some of viral miRNAs share seed 
sequences with host miRNAs and at least three viruses: BLV, MDV-1, and Kaposi’s 
Sarcoma-associated Herpesvirus (KSHV) have been shown to regulate transcripts 
via the same target docking sites as their counterpart host miRNAs [46–48]. Such 
viral miRNAs could potentially regulate hundreds of transcripts having target sites 
for a particular host miRNA. Such regulatory networks could affect specific func-
tions such as inhibiting apoptosis.
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KSHV and MDV-1 express two distinct miRNAs, which are functional ortholog 
of host miR-155, a conserved cellular miRNA that is required for the rapid expansion 
of B and T cells after antigenic stimulation and highly expressed in activated myeloid 
and lymphoid cells [31, 46–48]. Interestingly, in both MDV-1 and KSHV-induced 
tumors, there is downregulation of endogenous levels of miR-155 [38, 47, 49],  
although the mechanisms for such downregulation is not fully understood. It is 
intriguing to know why these two viruses chose to express their own miR-155 ortho-
logs, while suppressing the host-encoded miRNA with potentially identical functions. 
The direct role of miR-155 on oncogenesis [50, 51] and induction of cancer [47, 52]  
have been shown by a number of studies. Furthermore, it has been shown that 
upregulation of miR-155 is associated with lymphocyte transformation by reticu-
loendotheliosis virus strain T (REV-T) [53, 54] and EBV [55]. It is therefore striking 
that mdv1-miR-M4-5p is highly expressed in MDV-1 transformed cells derived 
from MDV-1-induced T-cell lymphomas [31, 46]. Moreover, lymphoma induction 
in infected birds is greatly reduced with seed region mutagenesis or deletion of 
mdv1-miR-M4-5p, suggesting the importance of mdv1-miR-M4-5p in the induc-
tion of tumors [34, 35]. The fact that transformation ability of the miR-M4-deleted 
MDV-1 virus is partly restored by introduction of chicken miR-155, suggests that viral 
miRNAs can play a major role in enhancing the oncogenic potential of a herpesvirus 
in vivo. However, the oncogenicity of vvMDV strain GX0101 with mdv1-miR-M4 
deletion has significantly decreased but was not totally abolished [35]. This report, 
coupled with the finding that HVT with mdv1-miR-M4 inserted in the genome failed 
to induce tumors [32], suggested that other factors are also required for viral transfor-
mation. Moreover, our recent studies have shown that mdv1-miR-M4 is not essential 
for maintaining the proliferation of transformed cell lines suggesting that it has 
probably a more significant role in the initiation of neoplastic transformation [56].
miR-H14-3p, one of the HVT-encoded miRNAs, showed close sequence identity 
with perfect match of the 21/23 nucleotides including identical seed sequence to the 
chicken gga-miR-221, suggesting that it is a virus-encoded ortholog [27]. Indeed, 
the proposed ortholog status of the two miRNAs are supported by the evidence 
that HVT-miR-H14-3p also modulates the expression of p27Kip1 (cyclin-dependent 
kinase inhibitor 1B), a known target of miR-221 [57]. Compared to other known 
viral miRNA orthologs, where only the seed sequences are identical, the full length 
mature miRNA sequences of miR-H14-3p and gga-miR-221 are almost identical, 
strongly suggesting that hvt-miR-H14-3p is most likely to have been acquired 
from the host genome. This is the first example of virus-encoded miRNA show-
ing such close and extended sequence identity with a host miRNA. Furthermore, 
partial sequence conservation has been observed between the gga-miR-221 locus 
on chromosome 1 of the chicken genome and the downstream flanking region 
of hvt-miR-H14-3p in the HVT genome, suggesting hvt-miR-H14-3p is “pirated” 
by the virus from the host, despite of the fact that herpesviruses have frequently 
pirated and subverted host genes to their own purposes. Interestingly, p27Kip1, 
the target shared by the two miRNAs, is a regulator of the cell cycle G1 to S phase 
transition. MDV-1-induced tumorigenesis may also involve a similar mechanism as 
miR-221-mediated repression of p27 in cancer progression [58–60]. In order to sup-
port viral genome replication and to promote growth of infected cells for additional 
viral production, the downregulation of p27 could move the cell cycle to the S 
phase [32]. The sequence homology is also observed between mdv1-miR-M31 and 
miR-221 in the seed region [31], although it is limited to the minimal miRNA seed 
region at nucleotide positions 2–7. Although targeting of p27 by miR-M31-3p has not 
been experimentally validated, the finding that miR-M31 deleted virus reduced the 
mortality and gross tumor incidence of infected chickens significantly has implied 
that miR-M31 may act as potential oncogene by targeting p27 [61].
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gga-miR-29 is known to function both as an oncogene and a tumor suppres-
sor depending on the context [62]. Seed sequence homology has been observed 
between mdv2-miR-M21 and miR-29 suggesting the potential functional ortholog 
between the two miRNAs. In fact, blv-miR-B4, a BLV-encoded miRNA, has been 
shown to be a functional ortholog of host miR-29 [12]. Furthermore, RLCV-
encoded miR-rL1-6-3p and EBV-encoded miR-BART1-3p also share seed sequence 
with miR-29. Thus, a picture is emerging wherein several virus-encoded miRNAs 
are likely to target host pathways [63].
It is estimated that ~8% of avian virus-encoded miRNAs possess identical 
heptameric seed sequence with host miRNAs, thus could potentially act as func-
tional orthologs [7]. However, based on low abundance, untested biogenesis, and 
unknown functional relevance, it is not clear, whether all of the currently anno-
tated viral or host miRNAs are bona fide miRNAs, thus some seed matches between 
host and viral miRNAs could arise by chance. Therefore, any proposed functional 
orthologs between the viral and host miRNAs require further experimental 
validation.
5. Target identification of avian herpesvirus miRNAs
Although over 500 virus-encoded miRNAs have been identified, an in depth 
functional study is lacking for most. However, it is clear that virus-encoded miR-
NAs can target both cellular and viral mRNAs and this has been confirmed by 
several studies analyzing the mRNA targetome of the virus-infected cells [64]. The 
best characterized viral miRNA functions in supporting viral replication include 
regulating the latent-lytic switch; evading the immune response; promoting cell 
survival, proliferation, and/or differentiation. All of these functions should be par-
ticularly important during persistent infections. As viral miRNAs and proteins work 
synergistically to promote a cellular environment favorable to the completion of the 
viral life cycle, modulation of the host cell environment is achieved by multiple and 
partly redundant mechanisms. The identified targets of avian herpesvirus-encoded 
miRNAs are summarized in Table 1.
5.1 Viral targets of viral miRNAs
Compared to identification of cellular targets, identifying viral targets of viral 
miRNAs is more straightforward as viral genomes encode fewer candidate mRNAs. 
Known examples of viral targets include transcripts, which are antisense to the viral 
miRNA precursor and transcripts elsewhere with imperfect matches. Perhaps, the 
former one is the most straightforward examples of determining viral miRNA func-
tion as the perfect matching between the miRNA and its target would be predicted 
to result in a siRNA-like cleavage of the target mRNA if both are co-expressed. For 
example, iltv-miR-I5 that is antisense to ICP4 cleaves ICP4 mRNA [65]. ICP4, an 
immediate early viral transactivator, plays a key role in the induction of lytic repli-
cation. The ICP4 targeting by viral miRNAs is thought to mediate lytic/latent switch 
and render the latent state more robust [66]. Apart from iltv-miR-I5, iltv-miR-I6 
also maps antisense to the ICP4 gene. However, reporter assay on inhibition of 
luciferase activity by iltv-miR-I6 was not significant [65]. It has been proposed that 
this is due to the blockage of accessibility to the binding region following in silico 
folding of RNA containing the targets for iltv-miR-I5 and iltv-miR-I6. This is consis-
tent with the previous finding that target RNA folding is essential for the efficacy of 
designed siRNAs [67, 68]. Sequences antisense to known miRNA stem-loop struc-
tures may fold into stem-loop structures themselves at an increased propensity. 
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This strategy could allow a virus to express both the viral gene and encode miRNAs 
antisense to mRNA transcripts lying on the other strand.
Analysis of miRNA binding clusters on the MDV-1 genome by PAR-CLIP 
identified very strong binding clusters near the 5′ end of the genome. These clus-
ters essentially are antisense to the MDV-1 miRNAs miR-M2, miR-M3, miR-M4, 
and miR-M12, which are members of Meq-cluster, adjacent to each other, highly 
expressed and all located antisense to an MDV-1 mRNA encoding the viral R-LORF8 
protein [64]. Analysis of indicator constructs in co-transfected 293 T cells or trans-
duced MSB-1 cells confirmed that R-LORF8 is indeed targeted by all four miRNAs. 
Interestingly, expression of R-LORF8 gene in a form lacking the viral miRNA 
binding sites caused a substantial reduction in MSB-1 cell growth, suggesting that 
dysregulated expression of R-LORF8 can exert a deleterious effect in MDV-1-
transformed T cells. The molecular basis for this effect is not clear as the function of 
R-LORF8 in the viral life cycle is currently unknown. The same pattern is observed 
in MDV-2, where viral miRNAs (miR-M24, M25, M26, M27, M28, and M29) are 
transcribed from the DNA strand located antisense to R-LORF2. In addition, there 
are also some other miRNAs encoded by MDV-1, MDV-2, HVT, and DEV, which are 
antisense to certain viral transcripts [24–28], the possible regulatory roles of those 
miRNAs against their antisense mRNA transcripts require to be verified individually.
Table 1. 
Avian virus encoded miRNAs and proposed functions highlighted in this review.
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As described above, mdv1-miR-M4-5p is a functional ortholog of cellular 
miR-155. mdv1-miR-M4-5p is also the first avian herpesvirus miRNA known to 
target both viral and cellular mRNAs. In addition to the cellular targets shared with 
miR-155, mdv1-miR-M4-5p and mdv1-miR-M4-3p also target viral UL28 and UL32 
proteins, respectively. This provided the first evidence of late viral gene targeting 
by herpesviral miRNA [69]. Rather than 3′UTR, both target sequences are located 
in the coding region. UL28 and UL32 homologs, which are required for the cleavage 
and packaging of virion DNA in human herpesvirus 1 (HHV-1) have been found in 
all subfamilies of mammalian and avian herpesviruses. However, the role of UL28 
and UL32 in MDV-1 packaging has not been demonstrated. As UL28 and UL32 are 
involved in the later stages of MDV replication, it is possible that mdv1-miR-M4 
contributes in maintaining MDV-1 latency by downregulating the production of 
UL28 and UL32 and impairing late MDV morphogenesis and reactivation.
Following the observation of the increased viral pathogenicity or oncogenicity 
of infected chickens when mdv1-miR-M11 is deleted from Mid-cluster, the potential 
mechanisms mediated by miR-M11 has been investigated [61]. Meq gene has been 
predicated as candidate target gene by bioinformatics approach with RNAhybrid. 
Indeed, Meq as miR-M11 target has been confirmed by dual luciferase assay and 
qRT-PCR showing downregulation of Meq transcript level following virus infec-
tion. It has been suggested that the viral miRNAs in the Meq- or Mid-clusters 
cooperate with each other for establishing, maintaining latency, and/or triggering 
tumorigenesis.
ICP4 and ICP27, two MDV immediate-early (IE) genes, have been identified 
as potential targets for mdv1-miR-M7-5p by both bioinformatics prediction and 
subsequent experimental validation [70]. Indeed, this is reflected by a negative 
correlation between an increase in ICP27 expression and the decreased expression 
of mdv1-miR-M7-5p during virus reactivation. This is consistent with the early 
finding that miR-M7-5p is at extremely low levels in MDV-infected CEF but highly 
expressed in MSB-1 cells [25]. MDV miRNAs produced from LAT-cluster may con-
tribute to the latency by targeting two IE genes. These findings further support the 
view that herpesvirus miRNAs play a key role in controlling the lytic/latent switch 
during infection [71, 72].
5.2 Cellular targets of viral miRNAs
Viruses such as herpesviruses with latent infection need to keep the host cells 
alive long enough. Thus, viral miRNAs can promote virus replication through 
prolonging cell survival and evading immune recognition. Among avian virus-
encoded miRNAs, the targets of mdv1-miR-M4-5p are most extensively studied due 
to its critical role in virus induced oncogenesis. As viral orthologs of miR-155, both 
kshv-miR-K12-11 and mdv1-miR-M4 potentially target the same group of transcrip-
tion factors as gga-miR-155 including Pu.1, CEBPβ, HIVEP2, BCL2L13, PDCD6, 
MAP3K7IP2, GPM6B, RREB1, and c-Myb [46, 69]. Subsequent analysis of >1000 
cellular mRNAs targeted by MDV-1 miRNAs in MSB-1 cells using photoactivatable 
ribonucleoside-enhanced cross-linking and immunoprecipitation (PAR-CLIP) 
resulted in the identification of 73 mRNA 3′UTR targets for miR-M4-5p, of which 
nine (C1orf103, CSNK1A1, LATS2, MAP3K14, MYB, NR1D2, RORA, RPS6KA3, 
and WEE1) had previously been identified as targets for miR-155 or kshv-miR-
K12-11 in EBV-transformed human B cells and KSHV-transformed human B cells, 
respectively [64]. Indicator analysis of these 3′ UTRs gave data consistent with the 
hypothesis that these mRNAs are indeed targets for both miR-M4 in MSB1 and 
miR-155 in human B-cell lymphomas. Four additional mRNA targets (FCHSD2, 
JARID2, PBEF1, and RAP2A) were also conserved between miR-M4 in MSB-1 and 
Non-Coding RNAs
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miR-155 in EBV-transformed B cells. Among these mRNA targets, JARID2, a cell 
cycle regulator and part of a histone methyltransferase complex, has been shown 
to promote apoptosis and decrease cell survival when ectopically expressed [53]. 
WEE1 encodes a kinase that blocks cell-cycle progression and has been associated 
with inflammation and cancer [73]. MYB, a transcription factor, is involved in the 
regulation of hematopoiesis and tumorigenesis. Another interesting shared gene 
target for miR-155/miR-M4/miR-K12-11 is large tumor suppressor (LATS), which 
inhibits cell proliferation and promotes apoptosis by inhibiting YAP transcriptional 
activity through Hippo pathway. Being evolutionarily conserved from avian to 
mammal, loss of LATS expression is observed in many human cancers, including 
acute lymphoblastic leukemia [74]. These observations suggest a potential selec-
tive advantage for MDV-1 in inducing downregulation of LATS. Taken together, 
these observations provide additional evidence for the impact of miR-155 and its 
orthologs on pathways regulating lymphocyte activation, differentiation, apoptosis, 
proliferation, immune tolerance, and tumorigenesis [7].
In addition to the candidate mRNA targets described above, latent TGF-β bind-
ing protein 1 (LTBP1) has also been identified as bona fide host mRNA targets for 
miR-M4 [75]. Inhibition of LTBP1 expression by miR-M4-5p induced a significant 
decrease of TGF-β1 secretion and activation, with suppression of TGF- β signaling 
and upregulation of c-Myc expression. Interestingly, miR-155 has been shown to 
suppress TGF-β signaling through targeting SMAD2 and SMAD5 in human diseases 
[76, 77]. The KSHV-encoded miR-K12-11 also inhibits TGF-β signaling through 
downregulation of SMAD5 [78]. Thus, these findings indicate that dysregulation of 
the TGF-β signaling pathway by miR-155 and its viral orthologs may be a common 
feature shared by oncogenic herpesviruses. Interestingly, MDV1-encoded miRNA 
miR-M3 also suppress TGF-β signaling through targeting host gene SMAD2, and 
has been shown to suppress drug-induced apoptosis in cell culture [79], thus adding 
another layer of confidence to the conclusion that suppression of TGF-β signaling 
pathway is indeed involved in MDV-induced oncogenesis.
Another identified cellular target of miR-M4 is chicken heterogeneous nuclear 
ribonucleoprotein AB (hnRNPAB). HnRNPAB, a member of the hnRNP family pro-
teins, plays important roles in both normal biological processes and cancer develop-
ment. Downregulation of hnRNPAB expression promotes proliferation of both CEF 
and chicken fibroblast cell line DF-1 [80]. Hence, downregulation of hnRNPAB by 
miR-M4-5p may be one of the important strategies for MDV-1 to trigger the devel-
opment of MD lymphomas.
PAR-CLIP identified a list of 1104 cellular mRNAs targeted by MDV-1 miRNAs 
and a list of 1183 mRNAs targeted by MDV-2 miRNAs in MSB1, of which 419 mRNA 
targets were shared. Analysis of those cellular mRNAs identified several that were 
targeted by five or more different viral miRNAs in their 3′ UTRs, suggestive of a 
possibly important role in restricting innate antiviral immunity. IL-18, a proin-
flammatory cytokine induced upon infection by several different viruses, is able 
to stimulate IFN-γ production from T cells [81]. Surprisingly, chicken IL-18 gene 
contains seven viral miRNA target sites in its 3′ UTR [64]. Indeed, MSB1 cell growth 
is highly sensitive to inhibition by ectopic IL-18 expression. Whether this is due to 
induction of chicken IFN-γ expression remains to be determined. Thus, in addition 
to express viral interleukin-8 (vIL-8), which is required for disease progression and 
tumor development, this data suggest a second way in which MDV manipulates the 
host cell immune response.
Taken together, all of the data above suggests that latent/oncogenic viruses may 
proactively create a cellular environment beneficial to viral latency and oncogen-
esis through viral miRNA targeting cellular factors involved in antiviral processes 
including apoptosis. Surely, more targets of miRNAs encoded by avian viruses will 
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be identified with the advances in high-throughput technologies. We should be able 
to understand the role played by these small and highly effective modulators of gene 
expression once more targets of viral miRNAs are discovered and an integrated 
approach of demonstrating the functions and molecular pathways is developed.
6. Role of viral miRNAs in pathogenesis
Despite, several possible cancer-related genes have been identified as their 
targets of viral miRNAs, the direct in vivo role of those miRNAs such as KSHV-
encoded miRNAs in neoplastic diseases is difficult to demonstrate in the absence of 
suitable models. However, excellent disease models of infection by MDV in natural 
avian host allow examination of the oncogenic potential of virus-encoded miRNAs. 
As described above, it has been shown that the deletion of the Meq-clustered miR-
NAs from the viral genome by BAC mutagenesis abolished the oncogenicity of the 
virus. miR-M4 is essential for the virus in inducing tumor as the mutant virus with 
miR-M4 deletion or seed sequence mutation almost lost its oncogenicity, provid-
ing evidence for a direct in vivo role of a viral miRNA in tumor induction [34]. In a 
separate study, deletions of the Meq-cluster or miR-M4 alone from the viral genome 
of vvMDV strain GX0101 strongly decreased its oncogenicity [35]. Subsequent 
work demonstrated that except for mdv1-miR-M4, most of the other Meq-clustered 
miRNAs also play critical roles in MDV oncogenesis as both mortality and gross 
tumor incidence of birds infected with the mutant viruses have reduced signifi-
cantly for the corresponding virus with single miRNA deletion [82]. These studies 
provide further information for understanding the molecular determinants that 
trigger the development of tumors by oncogenic MDVs.
Having demonstrated the critical roles of Meq-clustered miRNAs in MD patho-
genesis and/or tumorigenesis, the role of miRNAs in Mid-cluster, which is tran-
scribed by the same promoter as the Meq-cluster in the latent phase of the infection 
has been investigated by infection of miRNA deleted virus in animal model [61]. 
The role of miR-M31-3p acting as oncogene and miR-M11-5p acting as tumor 
suppressor in MD lymphomagenesis have been proposed based on the decreased 
mortality and gross tumor incidence by miR-M31 deletion mutant and increased 
viral pathogenicity or oncogenicity of infected chickens when miR-M11 is deleted.
7. Conclusions
Recent advances in sequencing technology have led to the identification of a 
number of miRNAs encoded by avian viruses. Given their ability to target cellular 
and viral transcripts, and the lack of immune response, miRNAs represent an ideal 
mechanism of gene regulation during viral infection, latency, and persistence. Similar 
to host miRNAs, the determination of biologically relevant activities of the reported 
viral miRNAs is the next step forward. Although the function of most viral miRNAs 
is to be determined, evidence so far does support the view that viral miRNAs are key 
regulators in virus biology. By targeting key viral lytic genes directly or modulating 
cellular regulatory pathways indirectly, the virus-encoded miRNAs could contribute 
significantly toward switching between lytic and latent infections, thereby regulating 
viral pathogenesis in vivo. Whether a small or large number of critical miRNA-target 
interactions have functional significance is a key question to be answered.
It is crucial to define the miRNA targets for both understanding observed 
phenotypes and providing clues to their functional role. Genome wide biochemical 
screening are becoming more powerful approaches for the generation of reliable 
Non-Coding RNAs
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and accurate target information of viral miRNAs although target identification 
using target prediction software provided an initial strategy. Several techniques 
such as RIP-CHIP (RNA-binding protein immunoprecipitation microarray), HITS-
CLIP (high-throughput sequencing cross-linking and immunoprecipitation), PAR-
CLIP and proteomics analysis have all contributed large amount of data on potential 
targets of virus-encoded miRNAs [47, 83–89] although only PAR-CLIP has been 
used for avian herpesvirus miRNA targetome identification [64]. Cross-linking, 
ligation and sequencing of hybrids (CLASH) technology, another biochemical 
screen for miRNA targets, promises to generate the most accurate target informa-
tion to date, leading the way in the generation of high confidence target datasets 
which will be invaluable for future studies [90, 91]. These new technologies allow 
unprecedented and largely unbiased views into miRNAs-mediated regulation of 
gene expression in virus-infected cells. Undoubtedly, further studies using different 
approaches and technologies are required toward the clear definition of miRNAs 
targetome and their functional relevance in viral infection, latency, reactivation, 
and pathogenesis.
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